“BPC-157 or TB-500?” is one of the most common questions in regeneration research. Both are studied in repair-pathway models, but they are different molecules with different researched mechanisms. Here is the comparison, at a research-reference level.
What they are
BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a gastric protein. TB-500 is a synthetic fragment related to Thymosin Beta-4.
Researched mechanisms
BPC-157 is studied largely in angiogenesis, nitric-oxide pathway, and localized tissue-repair research. TB-500 is studied around actin regulation and cellular migration — a more systemic mechanism in the literature. They approach “repair” from different molecular angles.
Why they are often studied together
Because their researched pathways are complementary rather than overlapping, the two are frequently examined in combination. G13 offers a BPC-157 + TB-500 combination for exactly this kind of comparative work.
Both ship with independent, lot-matched HPLC COAs — verify any lot. For the wider category, see Regeneration Research Compounds. This is a research-reference comparison only; all compounds are for laboratory research use only and nothing here is a claim about outcomes or suitability for any application.